Efficacy of High-Dose and Low-Dose Simvastatin on Vascular Oxidative Stress and Neurological Outcomes in Patient with Acute Ischemic Stroke: A Randomized, Double-Blind, Parallel, Controlled Trial

Neurology Research International
Nattaphol UransilpSombat Muengtaweepongsa

Abstract

Stroke is the leading cause of death and long-term disability. Oxidative stress is elevated during occurrence of acute ischemic stroke (AIS). Soluble LOX-1 (sLOX-1) and NO are used as biomarkers for vascular oxidative stress that can reflect stabilization of atherosclerotic plaque. Previous study showed that simvastatin can reduce oxidative stress and LOX-1 expression. To evaluate neurological outcomes and serum sLOX-1 and NO levels in patients with AIS treatment with low dose 10 mg/day and high dose 40 mg/day of simvastatin. 65 patients with AIS within 24 hours after onset were randomized to treatment with simvastatin 10 mg/day or 40 mg/day for 90 days. Personal data and past history of all patients were recorded at baseline. The blood chemistries were measured by standard laboratory techniques. Serum sLOX-1 and NO levels and neurological outcomes including NIHSS, mRS, and Barthel index were tested at baseline and Day 90 after simvastatin therapy. Baseline characteristics were not significantly different in both groups except history of hypertension. Serum sLOX-1 and NO levels significantly reduce in both groups (sLOX-1 = 1.19 ± 0.47 and 0.98 ± 0.37 ng/ml; NO = 49.28 ± 7.21 and 46.59 ± 9.36 μmol/l) in 10 mg/day and 40 mg/day s...Continue Reading

References

Mar 1, 1997·Experimental Physiology·H Sies
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·M EndresJ K Liao
Oct 12, 2000·Biochemical and Biophysical Research Communications·H ChenJ L Mehta
May 15, 2002·Brain Research. Molecular Brain Research·David A SchwarzRichard A Maki
Jun 5, 2003·Annals of Neurology·Jieli ChenMichael Chopp
Mar 16, 2004·American Journal of Physiology. Heart and Circulatory Physiology·I V SmirnovaM S Goligorsky
Aug 11, 2006·The New England Journal of Medicine·Pierre AmarencoUNKNOWN Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators
Oct 14, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Chiara CuccurulloFrancesco Cipollone
Aug 19, 2008·International Journal of Stroke : Official Journal of the International Stroke Society·Niphon Poungvarin
Feb 13, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T KuwashiroT Kitazono
Apr 18, 2014·Journal of Stroke·Nijasri C Suwanwela
Nov 5, 2014·Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine·Majaz MoonisMarc Fisher
May 16, 2015·Current Neuropharmacology·Jingru ZhaoLili Cui
Sep 15, 2016·The American Journal of Emergency Medicine·İsmail AtikMustafa Keşaplı
Nov 21, 2017·Medical Gas Research·Zhou-Qing ChenGang Chen

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay

Clinical Trials Mentioned

NCT03402204

Software Mentioned

SPSS

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.